Home › Studies › PRJEB23292
PRJEB23292 ERP105031

Gut metagenome, bariatric surgery, France

Dysbiosis, including decreased gut microbial richness (MGR) and composition modifications, associates with adverse metabolism in lean, overweight or moderate obesity, but lacks characterization in severe obesity. Bariatric surgery (BS) improves body composition and metabolism in severe obesity which featuresand is associated with gut microbiota modifications. Here, we characterized the importance of dysbiosis and functional alterations in severe obesity and assessed whether BS procedures would rescue this dysbiosis.

271 gut metagenome samples from adults with obesity in France, studied in an intervention design comparing adjustable gastric banding and Roux-en-Y gastric bypass, with follow-up post-surgery. machine-written summary

271 samples · 867 runs · FR · Adult · 2019 · 2.21 Gbp / sample

Sources
✓Sequence archive 688✓Abstract / description 542✓Full text 813○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive688 sample values (country, subject id, timepoint)
✓ Abstract / description542 sample values (health condition, health condition detail)
✓ Full text813 sample values (antibiotic exposure, location locality, location site) · PMC7143256, PMC8536095
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult271
Condition
obesity271
Country
FR271
Body site
primary271
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 3 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 212 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 56 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 2.21 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

50 of 81 people sampled more than once (170 samples; median 3, up to 5 per person). Schedule stated by the source: “stool at 1, 3 and 12 months post-bariatric surgery” (time origin: surgery); stated follow-up 12 mo.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category271 100%
country271 100%271
health_condition271 100%271
subject_id201 74%201
antibiotic_exposure271 100%271
detailed_location271 100%
health_condition_detail271 100%271
location_locality271 100%271
location_site271 100%271
timepoint_label216 80%216
Papers (2)
  • Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. 2019 PMID 29899081 PMC7143256 own_data
  • Exploring Semi-Quantitative Metagenomic Studies Using Oxford Nanopore Sequencing: A Computational and Experimental Protocol. 2021 PMID 34680891 PMC8536095 unsure
Details
Archive description

Dysbiosis, including decreased gut microbial richness (MGR) and composition modifications, associates with adverse metabolism in lean, overweight or moderate obesity, but lacks characterization in severe obesity. Bariatric surgery (BS) improves body composition and metabolism in severe obesity which featuresand is associated with gut microbiota modifications. Here, we characterized the importance of dysbiosis and functional alterations in severe obesity and assessed whether BS procedures would rescue this dysbiosis. Methods61 Sixty-one severely obese subjects, candidate to adjustable gastric banding (AGB, n=20) or Roux-en-Y-gastric bypass (RYGB n=41), were enrolled. 24 of them were followed at 1, 3 and 12 months post-BS. Gut microbiota and serum metabolomeics were analyzed using shotgun metagenomics and LC-MS technology, respectively. ResultsLow gene richness (LGC) concerned was present in 75% of patients and associated with detrimental fat composition (increased trunk-fat mass) and cardiometabolic complications (type-2 diabetes, hypertension and its severity). 78 Seventy-eight metagenomic species (MGS) were signatures of LGC , among which 50 % associated with adverse body composition and metabolic phenotypes. Nine serum metabolites (including Glutarate, 3-Methoxyphenylacetic Acid, and L-Histidine) and functional modules containing protein families involved in their metabolism were strongly modified byassociated with MGR. Gut microbiome showed significant increase of MGR one-year post-BS. Yet, RYGB patients remained with major dysbiosis one year post-BS, despite better improvement of their metabolism compared to AGB. Conclusions: We found signatures of major dysbiosis in severe obesity which include decreased MGR and related-functional alterations linked with metabolic deteriorations. The lack of full rescue post-BS, plead call for added strategies to improve the gut microbiota ecosystem and microbiome-host interactions in severe obesity.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.57. Assay shotgun_dna.

  • host run.scientific_name · “human gut metagenome”
  • body site run.scientific_name · “human gut metagenome”
  • life stage study.description · “Sixty-one severely obese subjects, candidate to”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA5357218antibiotic_exposurenoR30.70paper.fulltext.methodsNo patients had received antibiotic treatment for three months pre-BS
SAMEA5357218countryFRR10.90sample.attr.geographic_location_country_and_or_seaFrance
SAMEA5357218health_conditionobesityR40.50study.descriptionSixty-one severely obese subjects
SAMEA5357218health_condition_detailAll subjects had severe obesityR40.50study.descriptionSixty-one severely obese subjects
SAMEA5357218location_localityParisR30.70paper.fulltext.methodsPitié-Salpêtrière Hospital Obesity Unit, Paris
SAMEA5357218location_sitePitié-Salpêtrière Hospital Obesity UnitR30.70paper.fulltext.methodsPitié-Salpêtrière Hospital Obesity Unit, Paris
SAMEA5357237subject_id105R10.70sample.name_rule:aliasAtox105_0
SAMEA5357237timepoint_label0R10.70sample.name_rule:aliasAtox105_0
Sequencing

867 runs over 271 samples · mean 0.76 Gbp per run (median 0.63 Gbp, total 661.55 Gbp; 867 runs with a base count) · layout SINGLE 867 · platform ABI_SOLID 867 · models AB 5500xl Genetic Analyzer (867) · 0% of runs with a Sandpiper profile · first public 2019-02-16

Authors (20)

Aron-Wisnewsky J first · Prifti E · Belda E · Ichou F · Kayser BD · Dao MC · Verger EO · Hedjazi L · Bouillot JL · Chevallier JM · Pons N · Le Chatelier E · Levenez F · Ehrlich SD · Dore J · Zucker JD · Clément K last · Alili R first · Le P · Wirth T

Downloads

PRJEB23292.csv.gz (7.7 KB) · parquet (80.2 KB) — all 271 samples, every field with route and confidence · PRJEB23292_determinations.csv.gz (12.5 KB) — 2,043 evidence rows

Samples (271 · every field this project has values for · hover a cell for its source)
Loading the sample table…